Stimulates Growth And Cell Reproduction By Mimicking Natural Growth Hormone Injection Pen Suitable For Patients Not Hypersensitive To Somatropin

Product Description:

Somatropin Injection is a widely used therapeutic product containing the active ingredient Somatropin, a synthetic form of human growth hormone. It is designed to stimulate growth, cell reproduction, and regeneration in patients who require hormone replacement therapy due to growth hormone deficiency or other medical conditions. This injection is available in various dosage forms, with the most common being an injection administered via a 3ml cartridge and injection pen, offering precision and ease of use for patients and healthcare providers alike.

Manufactured by several reputable pharmaceutical companies, including well-known names such as Pfizer and Novo Nordisk, Somatropin Injection is recognized for its reliability and quality. These various manufacturers ensure that the product is accessible worldwide, catering to different patient needs with multiple strength options. The injection is typically supplied in 3ml cartridges, which are compatible with specialized injection pens designed for accurate dosing and convenient administration. This combination of a 3ml cartridge and injection pen enhances patient compliance by enabling self-administration and minimizing discomfort during the injection process.

Somatropin Injection is available in various strengths, commonly offered as 5 mg and 10 mg per vial or cartridge, allowing healthcare professionals to tailor the dosage to the specific requirements of each patient. This flexibility is crucial in managing a range of conditions such as growth hormone deficiency in children and adults, Turner syndrome, chronic kidney disease, and muscle wasting associated with HIV/AIDS. The diverse strength options ensure that treatment can be optimized for efficacy and safety, providing the right amount of hormone replacement to achieve desired therapeutic outcomes.

While Somatropin Injection is generally well-tolerated, patients may experience some common side effects. Injection site reactions are among the most frequently reported, including redness, swelling, or discomfort where the injection is administered. Other common side effects may include headaches, edema (fluid retention causing swelling), and muscle pain. These adverse effects are typically mild to moderate and tend to improve as the body adjusts to the treatment. Nonetheless, it is important for patients to be monitored regularly by healthcare professionals to manage any side effects effectively and ensure the best possible results from their therapy.

The use of a 3ml cartridge in conjunction with an injection pen allows for a more controlled and hygienic administration of Somatropin Injection. Patients can benefit from the portability and convenience of the injection pen, which is designed to deliver precise doses from the 3ml cartridge, reducing the risk of dosing errors. This system is particularly beneficial for pediatric patients and those requiring long-term therapy, as it simplifies the process and improves adherence to prescribed treatment regimens.

In summary, Somatropin Injection is a vital medication for individuals needing growth hormone replacement therapy. Produced by various reputable manufacturers like Pfizer and Novo Nordisk, it comes in multiple strengths such as 5 mg and 10 mg per vial or cartridge, ensuring personalized treatment options. The product’s formulation in a 3ml cartridge and compatibility with an injection pen provide ease of use and accurate dosing, enhancing patient comfort and compliance. Despite some common side effects like injection site reactions, headache, edema, and muscle pain, Somatropin Injection remains a cornerstone in managing growth hormone deficiencies and related disorders, offering hope and improved quality of life to many patients worldwide.

Features:

• Product Name: Somatropin Injection
• Dosage Form: Injection
• Drug Class: Recombinant Human Growth Hormone (HGH)
• Active Ingredient: Somatropin
• Available in a 3ml cartridge compatible with injection pen
• Common Side Effects: Injection Site Reactions, Headache, Edema, Muscle Pain
• Prescription Status: Prescription Only

Technical Parameters:

Applications:

The Delfu Somatropin Injection, model number BZ-18, is a recombinant human growth hormone product originating from China. It is designed for patients requiring hormone therapy due to various medical conditions. This product is available in multiple strengths, such as 5 mg and 10 mg per vial, providing flexibility to meet individual treatment needs. The administration route for Delfu Somatropin Injection is either subcutaneous or intramuscular, often facilitated by an injection pen to ensure precise and convenient dosing.

The primary application occasions for Delfu Somatropin Injection include the treatment of growth hormone deficiency in both children and adults. Patients with this condition benefit from regular administration of the hormone to promote normal growth and metabolic functions. The injection pen makes the administration process more user-friendly, allowing patients or caregivers to administer doses accurately at home or in clinical settings.

Another important scenario for the use of Delfu Somatropin Injection is in managing Turner Syndrome, a genetic disorder affecting females characterized by short stature and gonadal dysgenesis. Growth hormone therapy, delivered via the injection pen, helps improve height outcomes and overall development. Furthermore, this product is indicated for children with chronic kidney disease who experience growth failure. The convenience of the injection pen supports adherence to treatment schedules in such chronic conditions.

Additionally, Delfu Somatropin Injection is used in treating Prader-Willi Syndrome, a complex genetic disorder associated with poor muscle tone and growth delays. The injection pen allows for consistent hormone delivery, which is critical for improving growth parameters and physical development in affected individuals.

While generally well-tolerated, common side effects associated with the use of Delfu Somatropin Injection include injection site reactions, headache, edema, and muscle pain. Patients using the injection pen should be informed about these potential reactions and advised to monitor their condition closely. Overall, the combination of Delfu’s reliable recombinant human growth hormone formulation with the ease of an injection pen makes it an effective option for managing growth-related disorders across various clinical scenarios.

Customization:

Our Somatropin Injection, branded as Delfu and model number BZ-18, is a high-quality human growth hormone product originating from China. This injection pen is designed for easy administration via subcutaneous or intramuscular routes, ensuring effective delivery of the human growth hormone. The mechanism of action involves stimulating growth and cell reproduction by mimicking natural growth hormone, making it a reliable choice for patients requiring growth hormone therapy.

Please note that Somatropin Injection is contraindicated in individuals with active malignancy, acute critical illness, or hypersensitivity to somatropin. Our product customization services allow for tailored dosage forms and packaging to meet specific patient needs, enhancing the convenience and efficacy of this essential hormone treatment.

Support and Services:

If you require technical support or additional services related to Somatropin Injection, please consult your healthcare provider or pharmacist for guidance. For detailed product information, including proper storage, administration instructions, and potential side effects, refer to the enclosed patient leaflet or the official prescribing information. It is important to follow all usage instructions carefully to ensure safety and effectiveness. For any adverse reactions or unexpected effects, report them promptly to your healthcare professional. Additional support materials and resources may be available through authorized healthcare channels.